| 1 |
35081907 | Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy. | 2022 Jan 26 |
4 |
| 2 |
35251212 | Resveratrol Inhibits High Glucose-Induced H9c2 Cardiomyocyte Hypertrophy and Damage via RAGE-Dependent Inhibition of the NF-κB and TGF-β1/Smad3 Pathways. | 2022 |
2 |
| 3 |
34157155 | Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers. | 2021 Oct |
4 |
| 4 |
34518478 | Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling. | 2021 |
2 |
| 5 |
28165488 | Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol. | 2017 Feb 6 |
2 |
| 6 |
26730840 | SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy. | 2016 Feb 15 |
1 |
| 7 |
24356887 | Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. | 2014 May |
2 |
| 8 |
21300041 | Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. | 2011 Mar 15 |
1 |